🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 10 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/02/2000 | 39,50 | 40,25 | 39,38 | 39,88 | -0,31% | 2,22% | 72.200 |
| 11/02/2000 | 39,00 | 40,13 | 38,00 | 40,00 | +5,26% | 5,45% | 57.400 |
| 10/02/2000 | 38,13 | 39,25 | 38,00 | 38,00 | +0,00% | 3,28% | 135.400 |
| 09/02/2000 | 40,50 | 41,00 | 37,69 | 38,00 | -6,17% | 8,18% | 289.400 |
| 08/02/2000 | 32,88 | 43,50 | 32,88 | 40,50 | +22,50% | 32,32% | 263.000 |
| 07/02/2000 | 33,13 | 33,25 | 32,75 | 33,06 | -0,19% | 1,51% | 242.800 |
| 04/02/2000 | 31,69 | 33,13 | 31,63 | 33,13 | +4,74% | 4,73% | 298.400 |
| 03/02/2000 | 31,69 | 31,69 | 30,50 | 31,63 | +1,40% | 3,75% | 215.800 |
| 02/02/2000 | 31,25 | 31,69 | 30,00 | 31,19 | -0,99% | 5,40% | 75.400 |
| 01/02/2000 | 31,00 | 31,50 | 31,00 | 31,50 | +1,61% | 1,61% | 248.000 |
| 31/01/2000 | 31,38 | 32,63 | 30,88 | 31,00 | -1,39% | 5,58% | 103.000 |
| 28/01/2000 | 31,50 | 32,00 | 31,31 | 31,44 | -1,37% | 2,18% | 443.600 |
| 27/01/2000 | 33,00 | 33,19 | 30,00 | 31,88 | -5,73% | 9,66% | 326.000 |
| 26/01/2000 | 37,25 | 37,38 | 29,50 | 33,81 | -9,83% | 21,14% | 301.000 |
| 25/01/2000 | 38,19 | 38,56 | 37,00 | 37,50 | -2,28% | 4,09% | 346.800 |
| 24/01/2000 | 39,25 | 39,63 | 38,19 | 38,38 | +0,66% | 3,66% | 372.600 |
| 21/01/2000 | 39,03 | 39,63 | 38,00 | 38,13 | -1,29% | 4,16% | 208.800 |
| 20/01/2000 | 38,03 | 39,88 | 38,03 | 38,63 | +4,22% | 4,85% | 199.200 |
| 19/01/2000 | 38,25 | 38,25 | 37,03 | 37,06 | -3,73% | 3,19% | 254.600 |
| 18/01/2000 | 35,78 | 38,50 | 35,78 | 38,50 | +7,60% | 7,60% | 277.000 |
| 14/01/2000 | 35,63 | 36,38 | 35,00 | 35,78 | +2,23% | 3,86% | 109.000 |
| 13/01/2000 | 34,41 | 36,88 | 33,34 | 35,00 | +3,70% | 10,26% | 260.400 |
| 12/01/2000 | 33,00 | 34,88 | 33,00 | 33,75 | +2,27% | 5,68% | 218.800 |
| 11/01/2000 | 30,00 | 33,25 | 30,00 | 33,00 | +11,16% | 10,83% | 293.200 |
| 10/01/2000 | 28,94 | 30,75 | 28,75 | 29,69 | +4,17% | 6,91% | 323.200 |
| 07/01/2000 | 28,50 | 29,00 | 27,28 | 28,50 | +4,83% | 6,03% | 60.400 |
| 06/01/2000 | 25,50 | 28,50 | 25,50 | 27,19 | +3,57% | 11,76% | 204.600 |
| 05/01/2000 | 27,19 | 27,56 | 25,75 | 26,25 | -3,45% | 6,67% | 167.200 |
| 04/01/2000 | 26,88 | 27,19 | 26,00 | 27,19 | +2,35% | 4,42% | 115.400 |
| 03/01/2000 | 27,66 | 27,66 | 24,50 | 26,56 | +15,49% | 11,41% | 410.400 |